Creatinine, Body Fluid
Runt Related Transcription Factor 1 (RUNX1) Gene Mutation Analysis
Testosterone,Total
Protein C, Total Antigen
CHIC2, 4q12 Deletion (FIP1L1 and PDGFRA Fusion), FISH, Bone Marrow
Tuberculosis Cell Mediated Immunity Antigen Response (QuantiFERON®-TB Gold ) Test
Bacterial Vaginosis Pathogens by Molecular Method
Gliadin (Deamidated) Antibodies IgG and IgA
CD4/CD8 Lymphocyte Ratio, Bronchoalvolar lavage
Subcutaneous Fat Aspirate
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Specimen Collection
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...